1. Home
  2. APRE vs LUCY Comparison

APRE vs LUCY Comparison

Compare APRE & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • LUCY
  • Stock Information
  • Founded
  • APRE 2006
  • LUCY 2017
  • Country
  • APRE United States
  • LUCY United States
  • Employees
  • APRE N/A
  • LUCY N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • LUCY Ophthalmic Goods
  • Sector
  • APRE Health Care
  • LUCY Health Care
  • Exchange
  • APRE Nasdaq
  • LUCY Nasdaq
  • Market Cap
  • APRE 21.3M
  • LUCY 18.5M
  • IPO Year
  • APRE 2019
  • LUCY 2022
  • Fundamental
  • Price
  • APRE $2.92
  • LUCY $6.72
  • Analyst Decision
  • APRE Strong Buy
  • LUCY Strong Buy
  • Analyst Count
  • APRE 2
  • LUCY 1
  • Target Price
  • APRE $15.50
  • LUCY $20.00
  • AVG Volume (30 Days)
  • APRE 13.3K
  • LUCY 693.4K
  • Earning Date
  • APRE 11-07-2024
  • LUCY 11-12-2024
  • Dividend Yield
  • APRE N/A
  • LUCY N/A
  • EPS Growth
  • APRE N/A
  • LUCY N/A
  • EPS
  • APRE N/A
  • LUCY N/A
  • Revenue
  • APRE $1,310,839.00
  • LUCY $1,561,506.00
  • Revenue This Year
  • APRE $116.72
  • LUCY $245.17
  • Revenue Next Year
  • APRE N/A
  • LUCY $258.97
  • P/E Ratio
  • APRE N/A
  • LUCY N/A
  • Revenue Growth
  • APRE 130.31
  • LUCY 158.62
  • 52 Week Low
  • APRE $2.15
  • LUCY $3.26
  • 52 Week High
  • APRE $8.85
  • LUCY $27.20
  • Technical
  • Relative Strength Index (RSI)
  • APRE 34.50
  • LUCY 45.17
  • Support Level
  • APRE $2.87
  • LUCY $6.63
  • Resistance Level
  • APRE $3.35
  • LUCY $7.09
  • Average True Range (ATR)
  • APRE 0.32
  • LUCY 0.50
  • MACD
  • APRE -0.12
  • LUCY -0.06
  • Stochastic Oscillator
  • APRE 4.50
  • LUCY 5.88

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands free.

Share on Social Networks: